Riskpilot← Back to searchSign inGet full accessCOMPOUND AS
ASActiveOrg 927387646Kirkegårdsgata 4A, 0558 OsloWholesale of information and communication equipment · NACE 4650Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-533% vs 2023
Equity ratio
-52.4%
Financial strength
Net profit 2024
NOK -18K
-347% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -6K | -533% |
| Net profit | NOK -18K | -347% |
| Total assets | NOK 24K | -31% |
| Equity | NOK -13K | -364% |
| Employees | 0 | — |
Legal name
COMPOUND AS
Org number
927387646
Legal form
Aksjeselskap
NACE code
4650 · Wholesale of information and communication equipment
Founded
7. juli 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder eller nestleder hver for seg.
Company purpose
Import, eksport og handel med legemidler og helseprodukter, herunder direktesalg og distribusjon av generelle legemidler samt øvrige helsepleieprodukter.
Address
Kirkegårdsgata 4A, 0558 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −16 | −1 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −12 |
| EBIT | −6 | −16 | −1 | −18 |
| Net financials | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | −16 | −1 | −18 |
| Tax | −0 | −0 | 3 | −0 |
| Net profit | −6 | −16 | −4 | −18 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 24 | 18 | 35 | 24 |
| Equity | 24 | 9 | 5 | −13 |
| Long-term debt | 0 | 9 | 21 | 27 |
| Short-term debt | 0 | 0 | 10 | 10 |
| Total debt | 0 | 9 | 30 | 37 |
EBITDA margin
-566600.0%
This company
15.8%
Market median
-3586176% vs market
20212024
Equity ratio
-52.4%
This company
38.2%
Market median
-237% vs market
20212024
Return on equity
-1750500.0%
This company
18.4%
Market median
-9513687% vs market
20212024
Net profit margin
-1750500.0%
This company
8.1%
Market median
-21611211% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
2.91×
This company
0.62×
Market median
-369% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.3% | 33.3% | 2022 | |
Enkerlin Invest As | Company | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Enkerlin Invest As
COMPOUND AS Board members of COMPOUND AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ornela Ademi | Board of Directors | 0 companies |
| Gilberto Sanchez Enkerlin | Board of Directors | 0 companies |
| Audun Nilsen | Chairman | 0 companies |
| Stefan Ali | Board of Directors | 0 companies |
| Vinh Phan | Board of Directors | 0 companies |